Patient Power®
Get Email Alerts!
Health Topics
View all Health Topics >
Spring Survey 2012 Results
Browse Programs: by Health Topic | by Date | by Expert | by Sponsor

Programs > by Expert > Mark Kirschbaum, M.D.

Please use the links below to search by the first letter of a expert's last name or use the tabs above to browse by health topic, date or sponsor.

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Can't find what you're looking for? Try our search engine or view all Medical Experts.

Mark Kirschbaum, M.D.
Director, New Drug Development
City of Hope
Dr. Kirschbaum is the director of New Drug Development for the Division of Hematology & Hematopoietic Cell Transplantation at City of Hope. He also serves as hematologic malignancies coordinator for the California Cancer Consortium, a vital part of City of Hope's federally funded grant for phase I and phase II clinical trials through the National Institutes of Health (NIH) Cancer Therapy Evaluation Program (CTEP). His special interests include preclinical and clinical studies using molecular and epigenetic based therapies for hematologic malignancies. Dr. Kirscbaum’s current projects include creating optimal nontoxic targeted treatments for leukemia and lymphoma.

Learn more about Mark Kirschbaum, M.D.

Programs:
12/11/2007 - Exciting Early Follicular Lymphoma Clinical Trial Results Program Details >>

Back to Program Replay Library | Back to by Programs Expert